Amylyx Pharmaceuticals, Inc. (AMLX) vs Perrigo Company plc (PRGO)
- Amylyx Pharmaceuticals, Inc. AMLX 26.34 −4.74%
- Perrigo Company plc PRGO 16.63 +0.91%
Amylyx Pharmaceuticals, Inc. and Perrigo Company plc are both Drug Manufacturers Specialty & Generic companies. Amylyx Pharmaceuticals, Inc. is the larger, with a market value of $3.5B against $2.3B — 1.5× the size. Perrigo Company plc grew revenue faster over the last twelve months: −4.19% against −77.1%. Amylyx Pharmaceuticals, Inc. has the higher net margin (0.00% vs −41.9%) and the higher return on invested capital (0.00% vs −18.1%). Across the 17 metrics below, Perrigo Company plc leads on 10 and Amylyx Pharmaceuticals, Inc. on 7.
Valuation
Profitability
| Metric | AMLX | PRGO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | (42.65%) | 33.26% | 53.94% |
| Operating margin | 0.00% | (37.71%) | 0.00% |
| Net margin | 0.00% | (41.85%) | 0.00% |
| Free cash flow margin | 0.00% | 2.88% | 0.00% |
| Return on equity | (74.73%) | (49.65%) | (0.40%) |
| Return on assets | (66.25%) | (19.60%) | (3.32%) |
| Return on invested capital | 0.00% | (18.06%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack